Sanofi
-
{
- All
- News
- Videos
-
Sun Pharma, Cipla And More — Nirmal Bang's Top Stock Picks In Pharma Pack; Q1 Results Preview
- Friday July 11, 2025
- Author: Nirmal Bang Institutional Research
Nirmal Bang expects Ajanta Pharma, Dr. Reddy's, JB Chemicals, Eris, Sun Pharma, and Lupin to outperform the IPM.
-
www.ndtvprofit.com
-
Buy Sun Pharma, Add Metropolis Lists HDFC Securities Among Others In Pharma, Healthcare; Q1 Results Preview
- Thursday July 10, 2025
- Author: HDFC Securities Institutional Equities
Overall, HDFC Securities expects strong performances from Lupin, Ipca, and Torrent, while Aurobindo, Zydus, and Max Healthcare may post muted results.
-
www.ndtvprofit.com
-
Stocks To Watch: Axis Bank, Tech Mahindra, SBI Life, Power Grid, Container Corp, BHEL
- Friday April 25, 2025
- Author: NDTV Profit Research
L&T Technology Services, Indian Energy Exchange and SBI Cards will be also among the stocks to watch.
-
www.ndtvprofit.com
-
Corporate Actions This Week — CIE Automotive, Muthoot Finance, Sanofi India, Sterlite Tech
- Sunday April 20, 2025
- Author: Shubhayan Bhattacharya
The ex-date, which mostly coincides with the record date, marks when the share price adjusts to reflect the upcoming dividend payout.
-
www.ndtvprofit.com
-
India Pharma — Slowdown Across Categories Drags IPM Growth In February: ICICI Securities
- Wednesday March 12, 2025
- Author: Usha Kunji
Better traction in cardiac brands drove outperformance for JB Chemicals, Ipca, Zydus, Mankind, Glenmark, Lupin and Pfizer, says ICICI Securities.
-
www.ndtvprofit.com
-
Pharma Q3 Preview — Nirmal Bang Projects U.S. Pricing Pressure To Ease; Lists Stocks To Buy, Sell, Hold
- Wednesday January 15, 2025
- Author: Nirmal Bang Institutional Research
The U.S. business is expected to grow by ~8% YoY in CC terms mainly on the back of gRevlimid and gSpiriva and new launches, but it is expected to remain almost flat QoQ, adds the brokerage.
-
www.ndtvprofit.com
-
India Pharma - High Base Moderates IPM Growth For October: Motilal Oswal
- Wednesday November 13, 2024
- Author: Motilal Oswal Financial Services
Out of the top 40 brands, Monocef /Calpol /Azithral /Pantop posted a decline of 26%/26%/24%/10% YoY in Oct-24, adds the brokerage.
-
www.ndtvprofit.com
-
Goldman, Citi Among 22 Banks On CD&R’s Buyout Of Sanofi Unit
- Thursday October 17, 2024
- Author: Bloomberg News
Banks are eager to return to funding leveraged buyouts after the first Federal Reserve interest rate cut in four years raised hopes that debt costs are finally starting to ease.
-
www.ndtvprofit.com
-
India Pharma - Acute Therapies Drag Overall IPM Growth For September: Motilal Oswal
- Thursday October 17, 2024
- Author: Motilal Oswal Financial Services
JB Chemical outperformed IPM, led by a low base and strong performance across the top four therapies in Sep, says the brokerage.
-
www.ndtvprofit.com
-
Sanofi Consumer Healthcare: Promoter Hoechst Exits Firm, Sells Stake Worth Rs 6,927 Crore To Opella Healthcare
- Thursday October 10, 2024
- Author: Prajwal Jayaraj
Hoechst has completely divested its 60.37% stake in Sanofi Consumer Healthcare through a block deal valued at Rs 6,927 crore.
-
www.ndtvprofit.com
-
Sanofi Consumer Healthcare: Promoter Hoechst Exits Firm, Sells Stake Worth Rs 6,927 Crore To Opella Healthcare
- Thursday October 10, 2024
- Author: Prajwal Jayaraj
Hoechst has completely divested its 60.37% stake in Sanofi Consumer Healthcare through a block deal valued at Rs 6,927 crore.
-
www.ndtvprofit.com
-
Panacea Biotec, Sanofi Settle Patent Dispute Over Hexavalent Vaccine
- Monday September 16, 2024
- Author: Shreya Sur
Panacea Biotec initially filed the lawsuit in May 2021, seeking to stop Sanofi from marketing its Shan6 vaccine, which it believed infringed on Panacea’s patent for its wP-IPV based EasySix vaccine.
-
www.ndtvprofit.com
-
Sun Pharma, Cipla And More — Nirmal Bang's Top Stock Picks In Pharma Pack; Q1 Results Preview
- Friday July 11, 2025
- Author: Nirmal Bang Institutional Research
Nirmal Bang expects Ajanta Pharma, Dr. Reddy's, JB Chemicals, Eris, Sun Pharma, and Lupin to outperform the IPM.
-
www.ndtvprofit.com
-
Buy Sun Pharma, Add Metropolis Lists HDFC Securities Among Others In Pharma, Healthcare; Q1 Results Preview
- Thursday July 10, 2025
- Author: HDFC Securities Institutional Equities
Overall, HDFC Securities expects strong performances from Lupin, Ipca, and Torrent, while Aurobindo, Zydus, and Max Healthcare may post muted results.
-
www.ndtvprofit.com
-
Stocks To Watch: Axis Bank, Tech Mahindra, SBI Life, Power Grid, Container Corp, BHEL
- Friday April 25, 2025
- Author: NDTV Profit Research
L&T Technology Services, Indian Energy Exchange and SBI Cards will be also among the stocks to watch.
-
www.ndtvprofit.com
-
Corporate Actions This Week — CIE Automotive, Muthoot Finance, Sanofi India, Sterlite Tech
- Sunday April 20, 2025
- Author: Shubhayan Bhattacharya
The ex-date, which mostly coincides with the record date, marks when the share price adjusts to reflect the upcoming dividend payout.
-
www.ndtvprofit.com
-
India Pharma — Slowdown Across Categories Drags IPM Growth In February: ICICI Securities
- Wednesday March 12, 2025
- Author: Usha Kunji
Better traction in cardiac brands drove outperformance for JB Chemicals, Ipca, Zydus, Mankind, Glenmark, Lupin and Pfizer, says ICICI Securities.
-
www.ndtvprofit.com
-
Pharma Q3 Preview — Nirmal Bang Projects U.S. Pricing Pressure To Ease; Lists Stocks To Buy, Sell, Hold
- Wednesday January 15, 2025
- Author: Nirmal Bang Institutional Research
The U.S. business is expected to grow by ~8% YoY in CC terms mainly on the back of gRevlimid and gSpiriva and new launches, but it is expected to remain almost flat QoQ, adds the brokerage.
-
www.ndtvprofit.com
-
India Pharma - High Base Moderates IPM Growth For October: Motilal Oswal
- Wednesday November 13, 2024
- Author: Motilal Oswal Financial Services
Out of the top 40 brands, Monocef /Calpol /Azithral /Pantop posted a decline of 26%/26%/24%/10% YoY in Oct-24, adds the brokerage.
-
www.ndtvprofit.com
-
Goldman, Citi Among 22 Banks On CD&R’s Buyout Of Sanofi Unit
- Thursday October 17, 2024
- Author: Bloomberg News
Banks are eager to return to funding leveraged buyouts after the first Federal Reserve interest rate cut in four years raised hopes that debt costs are finally starting to ease.
-
www.ndtvprofit.com
-
India Pharma - Acute Therapies Drag Overall IPM Growth For September: Motilal Oswal
- Thursday October 17, 2024
- Author: Motilal Oswal Financial Services
JB Chemical outperformed IPM, led by a low base and strong performance across the top four therapies in Sep, says the brokerage.
-
www.ndtvprofit.com
-
Sanofi Consumer Healthcare: Promoter Hoechst Exits Firm, Sells Stake Worth Rs 6,927 Crore To Opella Healthcare
- Thursday October 10, 2024
- Author: Prajwal Jayaraj
Hoechst has completely divested its 60.37% stake in Sanofi Consumer Healthcare through a block deal valued at Rs 6,927 crore.
-
www.ndtvprofit.com
-
Sanofi Consumer Healthcare: Promoter Hoechst Exits Firm, Sells Stake Worth Rs 6,927 Crore To Opella Healthcare
- Thursday October 10, 2024
- Author: Prajwal Jayaraj
Hoechst has completely divested its 60.37% stake in Sanofi Consumer Healthcare through a block deal valued at Rs 6,927 crore.
-
www.ndtvprofit.com
-
Panacea Biotec, Sanofi Settle Patent Dispute Over Hexavalent Vaccine
- Monday September 16, 2024
- Author: Shreya Sur
Panacea Biotec initially filed the lawsuit in May 2021, seeking to stop Sanofi from marketing its Shan6 vaccine, which it believed infringed on Panacea’s patent for its wP-IPV based EasySix vaccine.
-
www.ndtvprofit.com